Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Reducing Visceral Fat Visceral fatstored deep in the abdomenis linked to heart disease and diabetes
Cardiometabolic Markers Regained weight usually brings blood sugar and cholesterol shifts
By Brian X
Taylor and Francis Ltd
The foundational characterization appeared in European Journal of Endocrinology in 1998, reporting selective agonism of the growth hormone secretagogue receptor type 1a (GHS-R1a) without significant elevation of ACTH, cortisol, prolactin, FSH, LH, or TSH, even at doses 200-fold above the GH-releasing ED50 in preclinical models
Automatically renews for $399 every 11 weeks, until cancelled) **See terms during checkout
US$ 25.15
US$ 22.33
US$ 22.62
US$ 27.78
US$ 25.46
US$ 26.71
US$ 24.28
US$ 21.45
